Dr Humaira Farooqi, PhD, MSc is an expert in Biochemistry at Jamia Hamdard (India). Humaira Farooqi has authored 56 publications, the most recent in 2026. SLR score: 190 (community average: 125). How the SLR is computed.

LeadR Profile

Dr Humaira Farooqi, PhD, MSc Jamia Hamdard India
190 ScienceLeadR Reputation 190
Network Map

Biochemistry

Subspecialties: Oncology - Nutrition - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2026

Source: PubMed

Jamia Hamdard

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 56

Citations

Citations: 662 1st author: 3 Last author: 21 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Serotonin Neurobiology and Artificial Intelligence-Driven Biomarker Detection in Affective Disorders: A Comprehensive Review.
PMID 42904642 — intelligence, neurobiology, mood disorders, biomarkers, machine learning, serotonin, therapeutics, learning, artificial intelligence, generalized anxiety disorder
ACS Chem Neurosci20260
Knowledge, attitude, and acceptance of euthanasia among medical students and doctors in Pakistan: A cross-sectional study.
PMID 42888629 — euthanasia, cross-sectional studies, physicians, education
Medicine (Baltimore)20260
Multiplexed impedimetric zinc oxide nanorods-modified aptasensor on carbon ink-inscribed paper electrodes for the specific and sensitive co-detection of Alzheimer's and Parkinson's disease.
PMID 42862409 — research design, parkinson disease, electrodes, biocompatible materials, biomarkers
Biomed Microdevices20260
Controlled microfluidic tank integrated AgNPs-coated paper-based impedimetric immunosensor for leukemia biomarker detection and complete validation through 3i-study in-silico, in-vitro, in-vivo.
PMID 42715745 — serum, microfluidics, leukemia, biomarkers, biotechnology
Biosens Bioelectron20260
Artificial intelligence, omics, and biomarkers: Redefining lung cancer early detection.
PMID 42105533 — intelligence, lung, early detection of cancer, neoplasms, biomarkers, lung neoplasms, learning, artificial intelligence
Curr Probl Cancer20260

LeadR Networks

Main global connection map